YOLFTbeta
00

Ildong Holdings Co Ltd

000230 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

5,490.00KRW+110.00 (+2.04%)

Price History

Full chart

Market Stats

Previous Close5,380.00
Open5,410.00
Day Range5,410.00 – 6,150.00
52-Week Range5,450.00 – 17,007.41
Volume12.38K
Market Cap67.63B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.69%
Beta0.19
50-Day Avg6,230.60
200-Day Avg9,119.35

About

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online; and manufactures original and generic prescription drugs. Further, it offers probiotics; pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions; and engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Woongseop Yoon
  • Employees136
  • Headquarters2, Baumoe-ro 27-gil, Seoul, South Korea, 06752, Korea
  • Websitehttps://www.ildongholdings.co.kr

Leadership

  • Mr. Wonyoung YoonPresident · b. 1938
  • Mr. Woongseop YoonCEO & Vice Chairman · b. 1967
  • Mr. Yong-Sik KangManaging Director and Director · b. 1960

Financials

Income Statement

Currency: KRW1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue117.56B149.22B185.35B212.01B239.05B280.57B310.01B344.58B361.58B376.93B395.94B347.16B348.47B362.78B395.23B417.52B38.30B40.77B41.07B47.05B292.22B596.47B592.37B675.54B638.45B634.65B590.89B
Growth (%)-+26.93%+24.21%+14.38%+12.76%+17.37%+10.49%+11.15%+4.93%+4.25%+5.04%-12.32%+0.38%+4.11%+8.94%+5.64%-90.83%+6.45%+0.73%+14.56%+521.09%+104.12%-0.69%+14.04%-5.49%-0.59%-6.90%
Cost of Revenue54.10B67.50B81.56B92.43B112.89B128.39B122.07B127.38B136.15B153.05B161.24B144.59B140.80B162.33B180.96B198.12B25.21B23.09B22.90B27.04B176.50B349.88B371.54B436.41B426.21B408.12B365.74B
Gross Profit--------------203.00B205.94B13.09B17.69B18.17B20.01B115.72B246.59B220.83B239.13B212.24B226.54B225.15B
Gross Margin--------------51.36%49.33%34.18%43.38%44.23%42.54%39.60%41.34%37.28%35.40%33.24%35.69%38.10%
Operating Expense--------------179.19B191.48B18.03B21.42B19.99B20.00B141.59B255.79B302.52B337.39B291.77B230.57B210.00B
Operating Income16.91B23.16B31.37B29.72B29.91B34.87B43.51B49.43B48.60B26.55B35.57B27.99B38.69B13.97B23.80B14.46B-4.94B-3.74B-1.83B18.90M-25.86B-9.20B-81.69B-98.26B-79.53B-4.03B15.15B
Operating Margin14.38%15.52%16.93%14.02%12.51%12.43%14.04%14.35%13.44%7.04%8.98%8.06%11.10%3.85%6.02%3.46%-12.89%-9.16%-4.45%0.04%-8.85%-1.54%-13.79%-14.55%-12.46%-0.63%2.56%
EBITDA------------------4.45B2.27B-21.69B16.48B-121.33B-116.29B-64.04B122.15B82.84B
EBITDA Margin------------------10.83%4.84%-7.42%2.76%-20.48%-17.22%-10.03%19.25%14.02%
Net Income4.60B7.28B9.87B13.76B14.08B9.85B20.32B23.12B22.63B18.14B32.85B18.59B27.30B16.89B6.48B11.86B20.98B265.99B651.62M-3.72B-22.46B-19.19B-70.89B-102.35B-59.59B63.04B10.93B
Net Income Margin3.91%4.88%5.33%6.49%5.89%3.51%6.56%6.71%6.26%4.81%8.30%5.35%7.83%4.66%1.64%2.84%54.78%652.39%1.59%-7.91%-7.69%-3.22%-11.97%-15.15%-9.33%9.93%1.85%
R&D-----------9.86B16.78B-29.27B21.99B227.79M1.18B6.55M246.66M31.68B68.45B109.84B119.44B107.98B55.70B35.49B
R&D as % of Total Revenue-----------2.84%4.82%-7.40%5.27%0.59%2.90%0.02%0.52%10.84%11.48%18.54%17.68%16.91%8.78%6.01%
Interest Expense00000000000000000002.29B4.60B6.65B15.12B17.23B30.10B32.35B23.18B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.86%1.57%1.11%2.55%2.55%4.71%5.10%3.92%

Balance Sheet

Currency: KRW1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets188.81B187.75B183.11B195.90B218.82B232.19B258.07B283.77B336.03B404.79B495.53B531.23B511.65B541.71B628.21B620.35B705.64B204.09B274.84B265.47B805.63B799.40B920.76B862.55B877.00B854.70B802.86B
Total Liabilities133.00B120.77B103.74B101.06B113.11B107.23B111.29B110.78B140.28B197.93B215.26B236.23B201.48B217.30B301.61B287.40B355.66B97.25B100.20B100.52B484.53B493.79B737.42B693.45B707.10B600.70B457.28B
Total Equity55.75B62.90B73.23B88.68B98.98B116.87B135.11B155.40B175.81B189.77B260.77B274.78B309.80B323.82B325.79B331.56B348.09B104.78B173.23B163.74B137.60B122.71B53.33B11.81B38.96B133.89B168.76B
Cash4.21B7.33B7.77B9.95B6.51B8.82B13.12B17.71B11.01B22.38B36.39B37.07B28.52B15.93B43.96B11.82B70.07B54.85B34.46B33.65B104.43B125.51B174.64B99.00B71.19B79.29B76.61B
Net Debt------------------31.57B33.72B128.70B114.86B146.15B202.12B239.81B238.28B117.44B

Cash Flow

Currency: KRW1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow10.66B17.98B23.62B14.37B4.23B24.34B19.35B36.60B16.23B-49.93B26.01B51.08B18.48B15.65B39.36B56.11B46.64B-2.19B6.23B14.34B8.24B-30.54B-74.59B-57.77B17.31B26.86B
Investing Cash Flow---------------58.65B-45.89B-39.86B-42.41B-19.06B-6.29B21.45B-24.69B-48.87B-32.50B---
Financing Cash Flow----5.18B---14.16B42.92B12.08B7.97B-6.14B71.06B-25.61B41.98B-19.46B862.40M-754.72M35.13B38.31B128.09B31.65B---
Capital Expenditure1.72B3.16B5.62B4.01B11.10B9.48B7.87B18.20B32.36B33.01B62.77B13.99B22.27B38.01B45.38B30.33B15.22B42.14B2.08B3.14B9.36B18.14B17.15B12.70B19.49B15.60B17.89B
Free Cash Flow-------------------4.43B3.03B-465.34M-14.78B-53.28B-95.73B-77.26B1.72B8.97B
Dividends Paid------2.61B2.98B2.98B3.88B3.39B4.36B3.39B4.36B3.66B3.91B4.86B7.32B1.07B2.09B2.08B1.09B1.19B1.31B1.38B1.21B60.16M
FCF to OCF------------------202.25%48.68%-3.24%-179.33%174.44%128.35%133.73%9.92%33.39%
Dividend Paid to FCF-------------------24.15%68.98%-446.70%-7.40%-2.23%-1.37%-1.78%70.20%0.67%

Earnings

Report DateAug 11, 2006Oct 31, 2006Jan 31, 2007May 2, 2007Jul 30, 2007Oct 29, 2007Jan 30, 2008Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Nov 28, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 14, 2016Feb 28, 2017May 15, 2017Aug 11, 2017Nov 13, 2017Feb 20, 2018May 15, 2018Jul 24, 2018Oct 19, 2018Feb 15, 2019May 29, 2019Aug 28, 2019Nov 14, 2019Feb 25, 2020May 13, 2020Aug 12, 2020Nov 12, 2020May 17, 2021Aug 17, 2021Nov 15, 2021Feb 17, 2022Apr 26, 2022Jul 27, 2022Oct 24, 2022May 10, 2023Aug 9, 2023Nov 6, 2023Feb 8, 2024May 9, 2024Jul 31, 2024Oct 30, 2024May 12, 2025Jul 29, 2025Oct 28, 2025Dec 31, 2025May 11, 2026Jun 30, 2026
EPS Estimate158.52176.85220.68223.49227.66235.46233.47---------------107.80---------------408.70----------------------------
EPS Actual193.34196.44146.71290.25161.37238.3781.63804.74488.76848.021170.80829.822.49808.58489.351045.09713.51-1572.271101.80609.01436.99311.97167.80234.281163.29588.76669.59303.31884.89927.7118026.29-297.7129.26-66.9345.9849.3725.87-64.6032.38-345.78605.26128.69-543.90-2178.75-227.8191.38-463.62-1190.68-75.52-564.07-4447.63-4849.421036.04-1050.57-4200.16-933.12-2262.90-980.87-542.0266.78-662.046401.25-460.1887.951705.08123.31-1.45
Surprise21.97%11.08%-33.52%29.87%-29.12%1.24%-65.04%---------------55.66%----------------92.08%----------------------------
TimingPre-marketAfter-hoursAfter-hours-After-hoursAfter-hours----------------After-hours------Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-----------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap67.63B
Enterprise Value173.76B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.11
Price / Book0.39
Revenue (TTM)607.65B
Gross Profit (TTM)237.55B
EBITDA52.25B
Profit Margin3.57%
Operating Margin2.32%
Return on Equity13.75%
Return on Assets1.84%
Shares Outstanding11.54M
Shares Float6.99M
Beta0.19
Dividend Yield1.69%
Dividend Rate100.00
Payout Ratio5.22%

Dividends

20261×
100.00Mar 30, 2026
20231×
100.00Dec 27, 2023
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
95.24Dec 27, 2019
20181×
190.48Dec 27, 2018
20171×
181.41Dec 27, 2017
20161×
136.05Dec 28, 2016
20151×
944.40Dec 29, 2015
20141×
629.60Dec 29, 2014
20131×
503.68Dec 27, 2013
20121×
472.20Dec 27, 2012
20111×
566.64Dec 28, 2011
20102×
440.72Dec 29, 2010566.64Mar 30, 2010
20091×
440.72Mar 30, 2009
20081×
503.68Mar 28, 2008
20071×
387.45Mar 29, 2007
20061×
387.45Mar 30, 2006
20051×
339.02Mar 30, 2005
20041×
242.15Mar 30, 2004
20031×
242.15Mar 28, 2003
20021×
242.15Mar 28, 2002

Stock Splits

  • Mar 5, 20201.05:1
  • Dec 27, 20181.05:1
  • Aug 31, 20160.2881:1
  • Apr 21, 20115:1
  • Mar 29, 20071.3:1